MK‑677 and Sleep – Not a Miracle but a Useful Tool?

Posted by greg208 in Research & News - 1 points, 0 comments.

I was reading the latest pre‑clinical paper on oral GH secretagogues and MK‑677 caught my eye. The authors ran a 12‑week trial in older men and reported that 20 mg daily lifted IGF‑1 by 30 % and improved subjective sleep depth scores. For me that’s interesting because I’ve struggled with sleep quality after my retirement. I tried MK‑677 in a trial group – took 15 mg at 8 p.m. – and by the third week I felt the first night of deeper, more restorative sleep. My sleep diary shows fewer awakenings and a steadier heart rate. There was a modest increase in appetite and a twinge of water retention that made my calves feel a bit học, but no obvious fatigue or joint pain. The paper also notes a slight rise in fasting glucose; I’m keeping tabs on that with a home glucometer.

Is the GH lift the real driver of the sleep improvement or is it just the ghrelin‑like appetite stimulus keeping me a bit calmer, or even a placebo effect? I’m curious if anyone else has tracked sleep with an objective tool (sleep tracker, polysomnography) while on MK‑677, and whether the 24‑hour GH exposure is actually better than a quick‑acting peptide like ipamorelin alone for sleep. In my experience the oral route is a game‑changer for dosing convenience, but I’d love to hear what others have seen – especially any data on long‑term safety or insulin sensitivity.

Community discussion - research and educational context only. Not medical advice.